Vertical Divider

DECEMBER 2020

Matthew State Awarded Yale Wilbur Cross for Alumni Achievement (link)

The Wilbur Lucius Cross Medal is an honor presented each year by the Graduate School Alumni Association to a small number of outstanding alumni. The medal recognizes distinguished achievements in scholarship, teaching, academic administration, and public service–all areas in which the legendary Dean Cross excelled.  Dr. State was awarded the 2020 medal for the Yale Department of Genetics.

Vertical Divider

JULY 2019

Susan and Bill Oberndorf Foundation makes $20 million commitment to Matthew State to advance UCSF Psychiatry's research efforts and public mission (Link)

The Susan and Bill Oberndorf Foundation has made a new commitment of $25 million to UC San Francisco. Twenty million dollars of the funds are unrestricted, to be used at the discretion of Matthew State, MD, PhD, chair and Oberndorf Family Distinguished Professor of Psychiatry.

Vertical Divider

DECEMBER 2018

Matthew State named among most highly cited researchers in the world (Link)

Matthew State and three UCSF Psychiatry faculty members have been acknowledged for the high impact of their research work with inclusion on the 2018 Highly Cited Researchers List. This highly prestigious honor recognizes scientists who have demonstrated significant influence through the publication of multiple highly cited papers over the last decade.
The Highly Cited Researchers list from Clarivate Analytics (formerly Thomas Reuters) is an annual compilation that identifies the most influential researchers in the sciences and social sciences from around the world.

Vertical Divider

OCTOBER 2017

Matthew State awarded National Academy of Medicine’s Sarnat Prize for Mental Health Research (Link)

The National Academy of Medicine (NAM) today awarded 2017 Rhoda and Bernard Sarnat International Prize in Mental Health to Joseph Coyle, whose research laid the foundation for integrating neuroscience and clinical psychiatry and shifted psychiatry’s emphasis toward empirically based brain research; and to the team of Catherine Lord and Matthew State, whose work revolutionized the study of autism and related neuropsychiatric disorders.
“Through their pioneering research and clinical work, Joseph Coyle, Catherine Lord, and Matthew State have made profound contributions to the understanding of a range of serious neuropsychiatric disorders,” said National Academy of Medicine President Victor J. Dzau.

Vertical Divider

AUGUST 2017

Matthew State’s iBiology Video Talk: From Genes to Pathology in Autism Spectrum Disorders (2017)

Matthew State overviews the hunt for genes associated with autism and explains how studying de-novo rare mutations in the germline has advanced the understanding of the genetics of autism spectrum disorder (ASD). Studying a cohort of families with one affected individual and one unaffected sibling, they were able to map multiple genes involved in ASD. Because of the complexity of the developing brain, the same gene could act upon different regions of the brain at different times during development. Therefore, after identifying genes associated with ASD, they characterized the region and time during development where these genes are expressed and more likely to have an effect that is associated with ASD.

Vertical Divider

JULY 2017

 State Lab:  Winner of the 2017 UCSF Sustainability Award in the Team Category (Link) and recognized for sustainability efforts by UCSF Chancellor Sam Hawgood (Link)

The members of the Department of Psychiatry's State Lab were among the UC San Francisco faculty, students, and staff members recognized for their efforts in supporting and advocating for sustainability measures at the seventh annual Sustainability Awards on June 20.
The lab in Rock Hall was recognized for its efforts in becoming the first laboratory ever to achieve a platinum-level certification in the UCSF LivingGreen program.

Vertical Divider

MARCH 2017

Matt highlighted in NIH news - Faster Sequencing, More Patients Boost Autism Research (Link)

A philanthropist’s largesse and faster sequencing technology are helping researchers gain footholds in understanding autism spectrum disorder, which affects between 1 and 2 percent of the population. But complex diseases of brain and behavior such as ASD will not yield soon to simple solutions, said Dr. Matthew State, chair of the department of psychiatry at the University of California, San Francisco, School of Medicine.

Vertical Divider

APRIL 2016

Podcast: CARRY THE ONE RADIO - Cracking The Autism Code With Matt State (Link)

Our ability to diagnose and treat disorders of the mind lags far behind other medical disciplines. For our latest episode, we talked to Dr. Matthew State about why this is the case, and discussed how his research into the genetics of autism is revealing promising paths to future treatments.

Vertical Divider

DECEMBER 2015

Recent Progress in Autism Genetics at the McGovern Institute for Brain Research at MIT​

The lecture will provide an overview of what is now known about the genomic architecture and specific risk mutations associated with ASD, address the particular challenges posed by the discovery of mutations that have large biological effect but low population allele frequency, and consider the role that whole genome sequencing will play in the near future in enhancing the understanding of the developmental aspects of ASD risk.

Vertical Divider

NOVEMBER 2015

Review in the Lancet Neurology - Gene hunting in autism spectrum disorder: on the path to precision medicine (Link)

Recent developments in gene-hunting technologies and methods, and the resulting plethora of genetic findings, promise to open new avenues to understanding of disease pathophysiology and to contribute to improved clinical management.

Vertical Divider

NOVEMBER 2012

The Brain Series - Autism — Charlie Rose

In this episode of the Brain Series, a panel of psychiatrists including Dr. Matthew State tackle the difficult subject of autism, and Alison Singer describes what it's like to raise an autistic child.